pd 98059 has been researched along with dexmedetomidine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KC; Jeong, YS; Kim, HJ; Kim, JG; Kwon, SC; Lee, SM; Ok, SH; Sohn, JT; Sung, HJ | 1 |
| Coburn, M; Eberhardt, G; Fahlenkamp, AV; Loetscher, PD; Rex, S; Rossaint, R; Schoeler, M; Weis, J | 1 |
| Qian, W; Qian, Y; Sun, L; Wang, J; Xiao, H; Zhang, X; Zhao, J | 1 |
| Chen, C; Gui, JB; Hu, SP; Liu, Y; Wang, WX; Wu, HF; Yu, L; Zhao, JJ | 1 |
4 other study(ies) available for pd 98059 and dexmedetomidine
| Article | Year |
|---|---|
c-Jun NHâ‚‚-terminal kinase contributes to dexmedetomidine-induced contraction in isolated rat aortic smooth muscle.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Anthracenes; Aorta; Dexmedetomidine; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Imidazoles; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Male; Muscle Contraction; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Protein Isoforms; Pyridines; Rats; Rats, Sprague-Dawley | 2011 |
Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury.
Topics: Analysis of Variance; Animals; Animals, Newborn; Brain Injuries; Cell Count; Dexmedetomidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Flavonoids; Hippocampus; Hypothermia, Induced; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Organ Culture Techniques; Time Factors | 2012 |
Dexmedetomidine inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated microglia by suppression of extracellular signal-regulated kinase.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cell Line; Dexmedetomidine; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Flavonoids; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Microglia; Nitric Oxide; Nitric Oxide Synthase Type II; Protein Kinase Inhibitors; Rats | 2015 |
Dexmedetomidine increases acetylation level of histone through ERK1/2 pathway in dopamine neuron.
Topics: Acetylation; Adrenergic alpha-2 Receptor Agonists; Analgesics, Non-Narcotic; Animals; Corpus Striatum; Dexmedetomidine; Dopaminergic Neurons; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Histones; Hypnotics and Sedatives; Male; Neuroprotective Agents; Oligonucleotide Array Sequence Analysis; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Receptors, Serotonin | 2017 |